But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug ...

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump administration invests in even more automation amid thousands of federal ...

FDA officials want to leverage AI for drug and device approval, animal testing, and data processing, as the Trump administrations slashes its workforce.

Posted: June 4, 2025 | Last updated: June 14, 2025 The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.

It takes the FDA an average of 10 months to review a new drug and six to nine months to review a high-risk device, such as a pacemaker or heart valve.

Nation & World Nation & World Politics Technology FDA to use AI in drug approvals to ‘radically increase efficiency’ June 10, 2025 at 4:55 pm By Christina Jewett ...